sulfamethoxazole has been researched along with 2019 Novel Coronavirus Disease in 3 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hayden, KR | 1 |
Jones, M | 1 |
Elkin, KR | 1 |
Shreve, MJ | 1 |
Clees, WI | 1 |
Clark, S | 1 |
Mashtare, ML | 1 |
Veith, TL | 1 |
Elliott, HA | 1 |
Watson, JE | 1 |
Silverman, J | 1 |
Richard, TL | 1 |
Read, AF | 1 |
Preisendanz, HE | 1 |
Chaves, MJS | 1 |
Kulzer, J | 1 |
Pujol de Lima, PDR | 1 |
Barbosa, SC | 1 |
Primel, EG | 1 |
Nibamureke, UMC | 1 |
Wagenaar, GM | 1 |
1 review available for sulfamethoxazole and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Updated knowledge, partitioning and ecological risk of pharmaceuticals and personal care products in global aquatic environments.
Topics: Aquatic Organisms; Ciprofloxacin; Cosmetics; COVID-19; Environmental Monitoring; Humans; Pharmaceuti | 2022 |
2 other studies available for sulfamethoxazole and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania.
Topics: Acetaminophen; Ampicillin; Animals; Anti-Bacterial Agents; COVID-19; Dexamethasone; Doxycycline; Env | 2022 |
Histopathological changes in Oreochromis mossambicus (Peters, 1852) ovaries after a chronic exposure to a mixture of the HIV drug nevirapine and the antibiotics sulfamethoxazole and trimethoprim.
Topics: Africa; Animals; Anti-Bacterial Agents; COVID-19; Female; HIV Infections; Humans; Nevirapine; Ovary; | 2021 |